Details of CPPsite entry with Sequence RLWMRWYSPRTRAYG |
| Primary information | |
|---|---|
| PEPTIDE SEQUENCE | RLWMRWYSPRTRAYG |
| CPPsite ID | 2734, 2859, |
| PEPTIDE NAME | 33, RLW |
| CHIRALITY | L, L |
| LINEAR/CYCLIC | Linear, Linear |
| SOURCE | Synthetic, Synthetic |
| CATEGORY | NA, NA |
| SUB CELLULAR LOCALIZATION | NA, NA |
| N-TERMINAL MODIFICATION | NA, Free |
| C-TERMINAL MODIFICATION | NA, Free |
| CHEMICAL MODIFICATION | NA, NA |
| UPTAKE EFFICIENCY | NA, NA |
| PROPOSED UPTAKE MECHANISM | NA, NA |
| INVITRO/INVIVO | In vitro and in vivo, In vitro and in vivo |
| CELL LINE | Many Human neoplastic cells including HeLa, Lovo, A549, MCF-7,MKN45,HepG2, LNCap, KPK,U2OS, RC-15,RD-ES,H28,K562,U251,NHDF, HUVEC and A549 cells |
| In VIVO MODEL | NOD-SCID mice model of xenograft human tumour cells, A549 xenografts bearing mice and U87 xenografts bearing mice |
| CARGO | Fluorophore (FITC), Nanoparticle (PEG-PCL) |
| PMID | 22805558, 25448586 |
| PATENT | Unknown, Unknown |
| Tertiary Structure (Technique) | 2734 (PEPstrMOD), 2859 (PEPstrMOD), |